Ready to talk to India to resolve differences over CPEC: China

Agencies
January 29, 2018

Beijing, Jan 29: China on Monday said it is ready to hold talks with India to resolve their differences on the contentious China-Pakistan Economic Corridor (CPEC).

"I noted the relevant report. Regarding the CPEC, China has repeatedly reiterated our position. As to the differences between China and India, China stands ready to communicate and hold talks with India to seek a proper solution so that these differences will not affect our general national interests. This best serves the interests of the two countries," Chinese foreign ministry spokeswoman Hua Chunying said.

She was responding to Indian Ambassador to China Gautam Bambawale's interview to state-run Global Times in which he had said that differences on the CPEC should not be swept under the carpet,

"We should not ask one party alone to solve this problem. We are willing to work with India to work with dialogue and communication for a better solution," she added.

"CPEC is merely an economic cooperation project. It has not targeted any third party. We hope the Indian side can put this in perspective and we stand ready to strengthen cooperation with the Indian side," Hua said.

India has objected to the USD 50 billion CPEC as it passes through Pakistan-occupied Kashmir (PoK).

The CPEC is a network of infrastructure projects that are currently under construction throughout Pakistan that will connect China's Xinjiang province with Gwadar port in Pakistan's Balochistan province.

India, China should resolve border differences in a calm way, says Beijing

Hua also said that India and China should look at their border differences, including over Dokalam, in a "calm way" and resolve them through existing mechanisms.

Reacting to Bambawale's interview, she said that differences can be addressed through existing mechanisms. "Indeed we have noted that the ambassador talked about it while addressing the issue," the Chinese foreign ministry spokesperson said.

"I should say the two sides should look at border issues in a calm way and resolve relevant issues through the existing border-related mechanisms so that we can create conditions and enabling the environment to properly solve our differences," she added.

Besides a mechanism to discuss border tensions, India and China also have special representative-level border talks to resolve the differences over the disputed border.

About the new satellite imagery showing buildup by both sides, Hua reiterated that Dokalam, over which Bhutan also claims sovereignty, is Chinese territory and said China is building facilities in the area.

She referred to the 1890 treaty between UK and China and said, "the Sikkim section of the China-India boundary has been demarcated by historic treaty and treaty under effective jurisdiction of China".

"China has always upheld our sovereignty along the border area including (Dokalam) Donglang," Hua said. About the satellite imagery, she said, "I should stress it (area) falls within China's sovereignty that we conduct facility building in Donglang area. Some Indian media have carried reports about the military buildup and infrastructure building in the area. They are very excited about it."

India and China ended a tense 73-day standoff on August 28 last year at Dokalam area after the People's Liberation Army (PLA) stopped building a strategic road close to India's narrow Chicken's Neck area connecting the northeastern states. Bhutan also claims the Dokalam area to be its part.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 6,2020

Seoul, Jun 6: South Korea on Saturday reported 51 new cases of COVID-19, mostly in the densely populated capital region, as authorities scramble to stem transmissions among low-income workers who can't afford to stay home.

The figures announced by South Korea's Centers for Disease Control and Prevention brought national totals to 11,719 workers and 273 deaths.

At least 34 of the new coronavirus cases were linked to door-to-door sellers hired by Richway, a Seoul-based health product provider.

Vice Health Minister Kim Gang-lip said the spread of the virus among Richway sellers was particularly alarming as most of them are in their 60s and 70s. He called for officials to strengthen their efforts to find and examine workplaces vulnerable to infections.

More than 120 infections have also been linked to a massive warehouse operated by Coupang, a local e-commerce giant, which has been accused of failing to properly implement preventive measures and having employees work even when sick.

South Korea was reporting around 500 new cases per day in early March due to a massive outbreak surrounding the southern city of Daegu, before officials managed to stabilize the situation with aggressive tracking and testing.

But the recent resurgence of COVID-19 in the greater capital area, where about half of South Korea's 51 million people live, is now threatening to erase some of the country's hard-won gains. It has also led to second-guessing whether officials were too quick to ease social distancing and reopen schools.

Health authorities and hospital officials on Friday participated in a table-top exercise for sharing hospital capacities between Seoul and nearby cities and ensure swift transports of patients so that a spike of cases in one area doesn't overwhelm its hospital system. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Washington, Apr 24: The number of coronavirus cases in the US has surpassed 850,000, Johns Hopkins University Coronavirus Resource Center data revealed on Thursday (local time).
The country now has registered 8,56,209 cases overall, according to the data, including 47,272 deaths.

The US currently leads the world in the number of reported COVID-19 deaths and confirmed cases.

There are more than 2.6 million COVID-19 cases around the world and more than 1,85,000 deaths, according to the data.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 28,2020

Canadian researchers are developing a DNA vaccine for SARS-CoV-2, the coronavirus that causes COVID-19 and has currently infected nearly 5,00,000 people worldwide and crippled the global economy.

Entos Pharmaceuticals, a health-care biotechnology company headed by a University of Alberta researchers, develop new therapeutic compounds using the company's proprietary drug-delivery platform and has begun manufacturing vaccine candidates against the novel coronavirus.

"Given the urgency of the situation, we can have a lead candidate vaccine within two months. Once we have that it's a race to get it into clinical trials," said John Lewis, CEO of Entos and a Professor at the University of Alberta in Canada.

Lewis said in comparison to a traditional vaccine, DNA-based vaccines hold several advantages.

Nucleic acids are introduced directly into the patient's own cells, causing them to make pieces of the virus--tricking the immune system into mounting a response without the full virus actually being present, the researcher said.

According to the company, the approach is recognised as being easier to move into large-scale manufacturing, offers improved vaccine stability and works without needing an infectious agent.

In the current absence of a vaccine for COVID-19, several companies around the world are mounting efforts to begin similar work.

The first clinical trial using a DNA-based vaccine developed by Moderna Inc.in the US on March 13.

Their approach allows for antibodies to be made in the human trial volunteers against a specific protein on the surface of the coronavirus that lets the virus enter human cells.

The hope is that the antibodies will stop the interaction.

Though this approach is designed to be effective against COVID-19 specifically, Lewis said Entos is taking a different tack.

The company plans to use plasmid DNA to amplify the production of key coronavirus surface and structural proteins with each injection, with an eye to the bigger picture.

"Many of the structural proteins in the virus are pretty well conserved across all the coronaviruses, including SARS and MERS," said Lewis.

"We're hoping that if we express more of the structural proteins that are common to most coronaviruses, we can inhibit the current COVID-19, and also potentially protect against all coronaviruses both past and future," Lewis added.

To move the project forward quickly, the company is seeking financial support from both provincial and federal levels of government.

"We have the opportunity to save a lot of lives, and I think it's really upon us and governments to find solutions for that," Lewis said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.